Trend

Last Previous Currency Date Chng
662.49 677.38 EUR 26/05/18 -2.20

Terms

Isin LU0190162189
Contract Type Sicav
Currency EUR
Class HR
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech Hdg EUR
Start Date 04/06/30
Advisor Name N.Av.
Fund Asset Under Management 95,7133  at 26/03/31

Performance

Cumulatives
1 month -4.60
Ytd +0.41
1 year +67.08
3 years +53.57
5 years +22.15
Yearly
04/30/2025 +45.63
04/30/2024 -3.91
04/30/2023 +10.09
04/30/2022 -18.70
04/30/2021 -10.29
Rating
Score
78.6572

Company

Pictet Am (Europe) S.A.
15, Avenue J.F. Kennedy L-1855 - Luxembourg
Tel. +39-02631195100

Costs

Entrance (ACP) Min: 3,0000 - Max: 3,0000
Management 2.3
Reimbursement 1%
Administrative 0%
Switch 2%
Tunnel 0

Subscription

One Solution
Initial 0,0000 EUR
Integrative 0,0000 EUR
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 0,0000

Costs

Entrance (ACP) Min: 3,0000 - Max: 3,0000
Management 2.3
Reimbursement 1%
Administrative 0%
Switch 2%
Tunnel 0

Performance

Cumulatives
1 day -2.20
1 week -3.14
1 month -4.60
3 months -0.08
6 months +5.69
From the beginning of the year +0.41
1 year +67.08
2 years +43.92
3 years +53.57
4 years +79.34
5 years +22.15
Yearly
04/30/2025 +45.63
04/30/2024 -3.91
04/30/2023 +10.09
04/30/2022 -18.70
04/30/2021 -10.29


Rating
Rating Rating Rating Rating
Score
78.6572

Efficiency Indicators

Sharpe 1 year 2.2841
Benchmark 1 year N.Av.
Sharpe 3 years 0.6128
Benchmark 3 years N.Av.
Sharpe 5 years 0.1535
Benchmark 5 years N.Av.
Sortino 1 year 7.758
Benchmark 1 year N.Av.
Sortino 3 years 1.0649
Benchmark 3 years N.Av.
Sortino 5 years 0.2252
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +20.08
3 years +23.28
5 years +22.20
Negative Volatility
1 year +5.91
3 years +13.40
5 years +15.14

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/04/30

Relative

Sharpe 0.6128
Sortino 1.0649
Bull Market +12.37
Bear Market +1.95
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,918 3 years 15,839 5 years 14,143
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,918
558
  
+57.19
3 years 15,839
2,837
  
+54.97
5 years 14,143
8,378
  
+15.27
Performance
558 +57.19 2,837 +54.97 8,378 +15.27
Total Volatility
1 year 17,918
20,746
  
+20.08
3 years 15,839
19,206
  
+23.28
5 years 14,143
16,726
  
+22.20
Total Volatility
20,746 +20.08 19,206 +23.28 16,726 +22.20
Negative Volatility
1 year 17,918
13,465
  
+5.91
3 years 15,839
19,108
  
+13.40
5 years 14,143
16,802
  
+15.14
Negative Volatility
13,465 +5.91 19,108 +13.40 16,802 +15.14
Sharpe Index
1 year 17,918
871
  
+2.28
3 years 15,839
8,101
  
+0.61
5 years 14,143
8,809
  
+0.15
Sharpe Index
871 +2.28 8,101 +0.61 8,809 +0.15
Sortino Index
1 year 17,918
570
  
+7.76
3 years 15,839
7,254
  
+1.06
5 years 14,143
8,774
  
+0.23
Sortino Index
570 +7.76 7,254 +1.06 8,809 +0.23

By Category

  1 year 17,918 3 years 15,839 5 years 14,143
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,918
3
  
+57.19
3 years 15,839
13
  
+54.97
5 years 14,143
32
  
+15.27
Performance
3 +57.19 13 +54.97 32 +15.27
Total Volatility
1 year 17,918
105
  
+20.08
3 years 15,839
111
  
+23.28
5 years 14,143
88
  
+22.20
Total Volatility
105 +20.08 111 +23.28 88 +22.20
Negative Volatility
1 year 17,918
7
  
+5.91
3 years 15,839
99
  
+13.40
5 years 14,143
83
  
+15.14
Negative Volatility
7 +5.91 99 +13.40 83 +15.14
Sharpe Index
1 year 17,918
1
  
+2.28
3 years 15,839
17
  
+0.61
5 years 14,143
28
  
+0.15
Sharpe Index
1 +2.28 17 +0.61 28 +0.15
Sortino Index
1 year 17,918
5
  
+7.76
3 years 15,839
16
  
+1.06
5 years 14,143
28
  
+0.23
Sortino Index
5 +7.76 16 +1.06 28 +0.23

Foreign Funds - Pictet-Biotech-Hr Eur: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.